223 related articles for article (PubMed ID: 35422570)
1. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
[TBL] [Abstract][Full Text] [Related]
2. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
3. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
[TBL] [Abstract][Full Text] [Related]
5. Is foxglove effective in heart failure?
Chaggar PS; Shaw SM; Williams SG
Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
[TBL] [Abstract][Full Text] [Related]
6. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
7. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
8. Non-compliance with digoxin in patients with heart failure and/or atrial fibrillation: a systematic review and meta-analysis of observational studies.
Kongkaew C; Sakunrag I; Jianmongkol P
Arch Cardiovasc Dis; 2012 Oct; 105(10):507-16. PubMed ID: 23062482
[TBL] [Abstract][Full Text] [Related]
9. Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Chen Y; Cai X; Huang W; Wu Y; Huang Y; Hu Y
Medicine (Baltimore); 2015 Dec; 94(52):e2409. PubMed ID: 26717399
[TBL] [Abstract][Full Text] [Related]
10. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
[TBL] [Abstract][Full Text] [Related]
11. Digoxin: The good and the bad.
Ziff OJ; Kotecha D
Trends Cardiovasc Med; 2016 Oct; 26(7):585-95. PubMed ID: 27156593
[TBL] [Abstract][Full Text] [Related]
12. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
Cheng JW; Rybak I
Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
[TBL] [Abstract][Full Text] [Related]
13. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
14. Digoxin in advanced heart failure patients: a question of rhythm.
Jorge E; Baptista R; Martins H; Saraiva F; Costa S; Vieira H; Coelho L; Monteiro P; Franco F; Providência LA
Rev Port Cardiol; 2013 Apr; 32(4):303-10. PubMed ID: 23528436
[TBL] [Abstract][Full Text] [Related]
15. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
Kytö V; Saraste A; Rautava P; Tornio A
Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
[TBL] [Abstract][Full Text] [Related]
17. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
[TBL] [Abstract][Full Text] [Related]
18. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
[TBL] [Abstract][Full Text] [Related]
19. Deleterious cardiovascular effect of exosome in digitalis-treated decompensated congestive heart failure.
Fu JL; Yu Q; Li MD; Hu CM; Shi G
J Biochem Mol Toxicol; 2020 May; 34(5):e22462. PubMed ID: 32045083
[TBL] [Abstract][Full Text] [Related]
20. Digoxin.
Eichhorn EJ; Gheorghiade M
Prog Cardiovasc Dis; 2002; 44(4):251-66. PubMed ID: 12007081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
